40 results on '"Resteghini C"'
Search Results
2. 224O Survival differences between EU and Asia for head and neck cancer: Results of the RARECAREnet-Asia collaboration
3. 708TiP BD4QoL: A multicenter randomized trial for monitoring quality of life (QoL) by intelligent tools in head and neck cancer (HNC) survivors after curative treatment
4. 664P A multicentre retrospective analysis of recurrent/metastatic (RM) nasopharyngeal cancer (NPC) from non-endemic areas: Results in the pre-immunotherapy era
5. 891P Pembrolizumab and olaparib in recurrent/metastatic, platinum resistant nasopharyngeal cancer: The POINT study
6. 856P Safety of neoadjuvant PARP inhibitor and immunotherapy in locally advanced HPV-negative head and neck squamous cell carcinoma (PRIME H&N Study)
7. Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding
8. 868P A phase II trial of induction chemotherapy (IC), photon-, proton- and carbon ion-based radiotherapy (RT) integration in locally advanced inoperable sinonasal epithelial tumors patients (pts)
9. 2221P Precision oncology in advanced thyroid carcinomas: Impact of molecular tests on patients’ outcomes
10. 1065P A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission
11. Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma
12. A phase II trial of dacomitinib in locally advanced unresectable or metastatic skin squamous cell carcinoma
13. Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer
14. A single institution twenty-year experience of recurrent or metastatic epithelial non glandular sinonasal cancer
15. Sinonasal non-glandular cancers relapsing after multimodal treatments
16. RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic squamous cell carcinoma of the head and neck (SUPREME-HN)
17. Baseline neutrophil-to-lymphocyte ratio is associated with outcome in recurrent/metastatic head and neck squamous cell cancer patients treated with platinum and cetuximab in first line setting
18. Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer: a single center experience
19. Retreatment with Vismodegib is active in progressive advanced Basal Cell Carcinoma: first report from a single-Institution experience
20. An added value to Multidisciplinary Team: does a Tutor help to manage head and neck cancer patients?
21. Health and economic outcomes of two different follow up strategies in effectively cured advanced head and neck cancer patients
22. RANK expression in EBV associated nasopharyngeal cancer metastasis in non-endemic setting: a possible immunologic pathway to be targeted?
23. Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area
24. Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer
25. Site of metastatic disease influences adenoid cystic cancer (ACC) patients' outcome
26. Outcome of systemic treatments after first line platinum and cetuximab treatment in patients with recurrent/metastatic (RM) head and neck squamous cell cancer (HNSCC): a retrospective analysis
27. L2 - Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma
28. L6 - Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer
29. L5 - A single institution twenty-year experience of recurrent or metastatic epithelial non glandular sinonasal cancer
30. G1 - A phase II trial of dacomitinib in locally advanced unresectable or metastatic skin squamous cell carcinoma
31. 1102P - Sinonasal non-glandular cancers relapsing after multimodal treatments
32. 1048PD - RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic squamous cell carcinoma of the head and neck (SUPREME-HN)
33. 993P - Baseline neutrophil-to-lymphocyte ratio is associated with outcome in recurrent/metastatic head and neck squamous cell cancer patients treated with platinum and cetuximab in first line setting
34. M05 - Retreatment with Vismodegib is active in progressive advanced Basal Cell Carcinoma: first report from a single-Institution experience
35. L03 - Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer: a single center experience
36. L10 - An added value to Multidisciplinary Team: does a Tutor help to manage head and neck cancer patients?
37. L09 - Health and economic outcomes of two different follow up strategies in effectively cured advanced head and neck cancer patients
38. L04 - RANK expression in EBV associated nasopharyngeal cancer metastasis in non-endemic setting: a possible immunologic pathway to be targeted?
39. Healthcare Associated Infections in Head and Neck Carcinoma Patients Treated with Chemotherapy and/or Radiotherapy
40. The Impact of Induction Chemotherapy on Cisplation Dose Intensity During Chemo-Radiotherapy (CTRT) in Oropharyngeal Squamous Cell Cancer (OPC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.